MAY 27, 2026 · REGULATORY APPROVAL
FDA approval: Losartan Potassium AND Hydrochlorothiazide
U.S. Food and Drug Administration
FDA approval of a generic fixed-dose combination of losartan potassium and hydrochlorothiazide; this is a regulatory action, not a clinical trial, and does not contain efficacy or safety data.
Reported
Approval date2026-05-27
Application typeANDA (Abbreviated New Drug Application)